A client presents to the emergency department in diabetic ketoacidosis (DKA) with a blood glucose of 550 mg/dL and is transferred to the intensive care unit. The client is started on 0.45% sodium chloride continuous infusion and intravenous insulin. Which finding indicates to the nurse that the client's intravenous fluid needs to be changed?

Nursing management of a client with Diabetic ketoacidosis focuses on restoring fluid balance, correcting electrolyte disturbances, and gradually lowering blood glucose. Initial treatment typically includes isotonic or hypotonic fluids followed by insulin therapy. As glucose levels decrease, the type of intravenous fluid must be adjusted to prevent hypoglycemia and cerebral edema. Continuous reassessment ensures that fluid therapy matches the client’s evolving metabolic status. Rationale: A. A potassium level decrease from 4.2 to 3.2 mEq/L is an important finding in DKA management, as insulin drives potassium into cells and can cause hypokalemia. However, this finding indicates the need for potassium replacement, not a change in intravenous fluid type. It requires electrolyte management rather than fluid adjustment. B. An increase in urine output from 20 to 35 mL/hour suggests improving renal perfusion and fluid status. This is generally a positive response to therapy and does not indicate a need to change intravenous fluids. It reflects improving hydration rather than deterioration. C. A blood glucose level of 252 mg/dL indicates that glucose has decreased significantly from initial levels and is approaching a threshold where fluid therapy must be adjusted. At this point, dextrose-containing fluids are typically required to prevent hypoglycemia while continuing insulin therapy. This finding signals the need to modify the intravenous fluid composition. D. Fruity breath odor is a classic sign of ketone production in DKA and may persist even as treatment progresses. Although it reflects ongoing metabolic acidosis, it does not directly indicate the need to change intravenous fluids. It is a clinical marker of disease process rather than a trigger for fluid adjustment.